- Home
- SNGX vs LGCB Comparison
SNGX vs LGCB Comparison
Compare SNGX & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- LGCB
- Stock Information
- Founded
- SNGX 1987
- LGCB 2011
- Country
- SNGX United States
- LGCB Japan
- Employees
- SNGX N/A
- LGCB N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- LGCB
- Sector
- SNGX Health Care
- LGCB
- Exchange
- SNGX Nasdaq
- LGCB Nasdaq
- Market Cap
- SNGX 7.4M
- LGCB 7.8M
- IPO Year
- SNGX 1987
- LGCB 2023
- Fundamental
- Price
- SNGX $2.43
- LGCB $0.23
- Analyst Decision
- SNGX
- LGCB
- Analyst Count
- SNGX 0
- LGCB 0
- Target Price
- SNGX N/A
- LGCB N/A
- AVG Volume (30 Days)
- SNGX 31.1K
- LGCB 196.7K
- Earning Date
- SNGX 03-14-2025
- LGCB 03-11-2025
- Dividend Yield
- SNGX N/A
- LGCB N/A
- EPS Growth
- SNGX N/A
- LGCB N/A
- EPS
- SNGX N/A
- LGCB N/A
- Revenue
- SNGX $364,183.00
- LGCB $10,289,681.00
- Revenue This Year
- SNGX N/A
- LGCB N/A
- Revenue Next Year
- SNGX $76.64
- LGCB N/A
- P/E Ratio
- SNGX N/A
- LGCB N/A
- Revenue Growth
- SNGX N/A
- LGCB N/A
- 52 Week Low
- SNGX $1.83
- LGCB $0.17
- 52 Week High
- SNGX $14.88
- LGCB $5.71
- Technical
- Relative Strength Index (RSI)
- SNGX 46.06
- LGCB 38.08
- Support Level
- SNGX $2.35
- LGCB $0.22
- Resistance Level
- SNGX $2.47
- LGCB $0.28
- Average True Range (ATR)
- SNGX 0.13
- LGCB 0.02
- MACD
- SNGX 0.04
- LGCB 0.00
- Stochastic Oscillator
- SNGX 61.36
- LGCB 24.85
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Copany operates in Japan, Hong Kong and China, with maximum revenue from Japan.